Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1121 studies found for:    "Osteoporosis"
Show Display Options
Download search resultsDownload the search results for:
"Osteoporosis" (1121 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
2 Completed
Has Results
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Drug: Previous denosumab
3 Active, not recruiting Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis, Steroid Induced
Intervention: Drug: Teriparatide
4 Completed Patient- and Physician-Based Osteoporosis Education
Conditions: Osteoporosis;   Osteoporosis, Postmenopausal
Intervention: Behavioral: Osteoporosis Education
5 Completed A Study for Teriparatide in Severe Osteoporosis
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis
Intervention: Drug: Teriparatide
6 Completed
Has Results
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
Conditions: Osteoporosis;   Postmenopausal Osteoporosis
Interventions: Drug: MK-5442;   Drug: Placebo to MK-5442;   Drug: Alendronate Sodium;   Drug: Vitamin D3;   Drug: Calcium carbonate;   Drug: Placebo to Alendronate
7 Completed PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
Conditions: Postmenopause;   Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH) (Preotact)
8 Unknown  Osteoporosis Coordinator for Low Volume Community Hospitals
Conditions: Osteoporosis;   Fragility Fractures
Interventions: Behavioral: centralized osteoporosis coordinator;   Behavioral: fall prevention
9 Completed Texture Analysis for Postmenopausal Osteoporosis
Conditions: Osteoporosis;   Osteopenia
Interventions: Drug: Alendronate;   Drug: Control
10 Completed Education for Osteoporosis in Persons With Existing Fractures
Condition: Osteoporosis
Interventions: Behavioral: Osteoporosis Prevention and Self-Management Course;   Behavioral: Introductory education session on osteoporosis
11 Unknown  Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
12 Completed Screening for Osteoporosis in General Practice
Condition: Osteoporosis
13 Completed Combination Osteogenic Therapy in Established Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: PTH 1-34;   Drug: MFPSR-fluoride
14 Not yet recruiting A Safety and Efficacy Study to Evaluate AMG 785 in South Korean Women With Osteoporosis.
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: Romosozumab;   Drug: Placebo
15 Completed A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Denosumab (CP2);   Drug: Denosumab (CP4)
16 Completed
Has Results
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: Denosumab
17 Completed A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: ALX1-11 50 mcg;   Drug: placebo;   Drug: ALX1-11 75mcg;   Drug: ALX1-11
18 Completed Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Bazedoxifene Acetate (TSE-424)
19 Completed
Has Results
Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis
Conditions: Osteopenia;   Osteoporosis
Intervention: Biological: Denosumab
20 Recruiting Preventing Osteoporosis Using Denosumab
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis;   Osteoporotic Fractures
Interventions: Drug: denosumab;   Drug: Placebo;   Dietary Supplement: Calcium and Vitamin D

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years